RESEARCH TRIANGLE PARK, N.C., July 5 /PRNewswire/ -- Quintiles Transnational Corp. today announced plans to expand and consolidate its Global Central Laboratories in Smyrna, Ga., and its Clinical Development Services (CDS) office in Atlanta within a single structure in nearby Marietta, Ga.
The 201,366-square-foot, three-story structure in Marietta will more than double the combined space now occupied by Global Central Laboratories in Smyrna and CDS in Atlanta, allowing for the addition of about 400 jobs through 2011. Renovation of the structure is expected to begin the third quarter of 2007, with the first groups of employees scheduled to move during the second quarter of 2008.
“For our Global Central Laboratories, this is another expansion to accommodate the growth of our business, following the additions of labs in China and India and expansion of our lab in Scotland,” said Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational. “The increasing demand for our CDS and laboratory services is driving the need to expand, and we’re taking this opportunity to bring our Atlanta units together to improve coordination and efficiency for our customers.”
Tom Wollman, Senior Vice President, Global Central Laboratories, said Quintiles wished to acknowledge the support of Cobb County, the Georgia Cancer Coalition, the Georgia Research Alliance and the Georgia Department of Economic Development for their support of this project. “With their help, Quintiles will be able to add up to 400 jobs in a rapidly expanding field. By more than doubling our capacity in the Atlanta area, we can stay ahead of the escalating demand for our services.”
The value of the incentive package is estimated at $11 million and includes training, collaborations with the Georgia Research Alliance Technology Fund and access to the Georgia Cancer Coalition and its Distinguished Cancer Clinician and Scientist Program. The Cancer Coalition has a network of more than 100 oncologists ready to work with Quintiles on new clinical trials.
The project is being managed by Solution Property Group and renovation is being done by Purdum Construction of Kansas City, Mo. Quintiles is investing $19 million in the project.
About Quintiles Global Central Laboratories
Quintiles Laboratories owns a network of clinically harmonized facilities in the U.S., Europe, South Africa, China, India and Singapore, and has tightly controlled sub-contractor laboratories in Argentina and Brazil managed by Quintiles employees located in each of the facilities.
About Quintiles
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With about 18,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company’s Web site at www.quintiles.com.
Quintiles Transnational Corp.
CONTACT: Dick Jones, Media Relations, +1-919-998-2091, ormedia.info@quintiles.com, or Greg Connors, Investor Relations,+1-919-998-2000, or invest@quintiles.com, both of Quintiles TransnationalCorp.
Web site: http://www.quintiles.com/
